Ceftriaxone sodium and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is reported as a side effect among people who take Ceftriaxone sodium (ceftriaxone sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Breast cancer.

The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Ceftriaxone sodium. It is created by eHealthMe based on reports of 6,546 people who have side effects when taking Ceftriaxone sodium from the FDA, and is updated regularly.

What is Ceftriaxone sodium?

Ceftriaxone sodium has active ingredients of ceftriaxone sodium. eHealthMe is studying from 6,549 Ceftriaxone sodium users. Check the latest studies of Ceftriaxone sodium.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,386 drugs and 3,836 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Feb, 28, 2026

6,546 people reported to have side effects when taking Ceftriaxone sodium.
Among them, 124 people (1.89%) have Atrial fibrillation/flutter.

Could Ceftriaxone sodium cause Atrial fibrillation/flutter?

Among these 124 people:

How long have people been on Ceftriaxone sodium when they have Atrial fibrillation/flutter? *

Click here to view more results

What is the gender of people who have Atrial fibrillation/flutter when taking Ceftriaxone sodium? *

Click here to view

What is the age of people who have Atrial fibrillation/flutter when taking Ceftriaxone sodium? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone sodium and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone sodium:

Ceftriaxone sodium (6,549 reports)

Atrial fibrillation/flutter treatments and more:

Atrial fibrillation/flutter (349,200 reports)

How severe was Atrial fibrillation/flutter and when was it recovered:

Atrial fibrillation/flutter in Ceftriaxone sodium

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Atrial fibrillation/flutter and drugs with ingredients of ceftriaxone sodium (866 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,386 drugs)

Browse all the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,836 conditions)

Related publications that referenced our studies

Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone sodium) and Ceftriaxone sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.